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Abstract: The carotenoids lutein and zeaxanthin (LZ) are found throughout the central nervous 
system but reach their highest concentration within the macular region of the primate retina 
where they are commonly referred to as the macular pigments. Although LZ are a major integral 
feature of the central fovea, no information currently exists regarding the effects of variability in 
the concentration of these pigments on the developing retina. In particular, the long-term effects 
of very low levels of macular pigment are not known and potentially meaningful. Macular pig-
ment levels depend upon dietary intake since LZ cannot be synthesized de novo. Infants with 
low intake of LZ (eg, infants receiving unfortiﬁ  ed infant formula or breast milk from mothers 
with low carotenoid diets) would be expected to have considerably lower macular pigment 
compared with infants with high LZ intake (eg, breast-fed infants with mothers on carotenoid-
rich diets). In this paper we discuss possible implications of this difference and the available 
evidence suggesting that LZ could inﬂ  uence the developing visual system.
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Introduction
The human macula is known to contain three yellow carotenoids, 3R,3’R-zeaxanthin, 
3R,3’S (meso)-zeaxanthin, and 3R,3’R,6’R)-lutein (Bone et al 1993). These carot-
enoids are absorbed in the gut and ultimately deposited throughout the tissues of the 
eye. In the macula, for instance, the average concentration of lutein and zeaxanthin 
(LZ) is about 1 mM which is about three times higher than the average concentration 
of carotenoids in other tissues of the body (Landrum et al 1999). This accumulation 
is conspicuous in terms of amount and selectivity. Of the 30–40 carotenoids typically 
found in the blood with very similar molecular conﬁ  gurations, only LZ are normally 
absorbed within ocular tissues. Within the eye, LZ are found in iridial tissue, the retinal 
pigment epithelium, the epithelium of the crystalline lens, and subretinal ﬂ  uid (Chan 
et al 1998; Bernstein et al 2001). This predominance of LZ extends throughout most 
layers of the visual system. Craft and colleagues (2004) found that LZ are the domi-
nant carotenoids within the brain comprising some 66%–77% of the total carotenoid 
concentration. The ubiquitous and selective presence of LZ within the visual system 
has led many researchers to believe that LZ play a special role in visual function and 
protection against visual disease. Although a number of comprehensive reviews have 
been written regarding the role of LZ in preventing age-related eye disease (cataracts 
and macular degeneration), a possible role of LZ in the early development of the 
visual system has received minimal attention. In this paper, we highlight the available 
evidence regarding possible functions of LZ early, as opposed to later, in life. 
Lutein and zeaxanthin within food
Carotenoids are found in most fruits and vegetables with the exception of some root veg-
etables (Scott et al 1996). There exists over 500 different types of carotenoids in nature, Clinical Opthalmology 2007:1(1) 26
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but only about 30–40 are found within human sera with lutein, 
lycopene, and betacarotene tending to be the most abundant 
depending on diet composition. Because humans do not 
synthesize carotenoids, all carotenoids found within tissue must 
originate from the diet (or related sources like human milk or 
supplements). The richest sources of LZ within the diet are dark 
green leafy vegetables like spinach and kale that can contain 
75–150 μg per gram of prepared food. Intermediate sources 
like broccoli, peas, maize, and lettuce can contain 10–30 μg per 
gram, and other sources like snap beans, carrots, and oranges tend 
to have less than 10 μg per gram (Holden et al 1999). Animal 
products like eggs and chicken skin can contain variable but 
signiﬁ  cant amounts of LZ especially when marigolds are added to 
chicken feed to improve yolk or skin coloration (NRC 1994). 
Lutein and zeaxanthin 
concentrations in breast milk 
and infant formula
The LZ content of breastmilk varies widely based on stage 
of lactation and individual diets (Table 1). The largest survey 
of breast milk carotenoids included 471 mothers from nine 
sites around the world (Canﬁ  eld et al 2003). In this survey, 
individual LZ milk concentrations ranged from 3–232 μg/L. 
Mean concentrations at individual sites (Table 1) ranged from 
approximately 15 μg/L in Australia, Canada, UK, and USA to 
approximately 43 μg/L in China and Japan. The average LZ 
concentration across all of these sites was 25 ± 19 μg/L.
In contrast to breast milk, commercial infant formulas 
generally contain only the LZ innate to the formula components. 
Using an HPLC method similar to Canﬁ  eld and colleagues 
(2003), Jewell and colleagues (2004) measured three samples 
each of six brands of infant formula (three term and three preterm) 
and found an average lutein concentration of 0.07 μg/L with a 
range from 0–0.13 μg/L of lutein. For zeaxanthin, the formulas 
contained an average concentration of 0.005 μg/L with a range 
from 0–0.022 μg/L of zeaxanthin. The HPLC method used by 
Jewell and colleagues (2004) includes a saponiﬁ  cation step that 
is known to reduce the recovery of LZ by approximately 40% 
(Liu et al 1998) and therefore it is likely that the true LZ content 
of both breast milk and formula is likely higher.
Differences in serum lutein and 
zeaxanthin between breastfed and 
formula-fed infants
A study of infant plasma carotenoid concentrations (Johnson 
et al 1995) showed that breastfed and formula-fed infants had 
similar plasma LZ concentrations at birth (48 ± 15 μg/L and 
49 ± 10 μg/L for breast and formula-fed, respectively). After 
one month, breastfed infant plasma LZ increased to 96 ± 64 
μg/L while formula-fed infant plasma LZ decreased below 
baseline to 33 ± 19 μg/L (Figure 1).
Similar trends have been observed for other infant plasma 
carotenoids, with plasma concentrations of betacarotene (Ostrea 
et al 1986; Sommerburg et al 2000), lycopene and cryptoxanthin 
Table 1 Published milk lutein concentrations
Location  Days postpartum  Lutein concentration (mcg/L)a Reference
Germany (n = 21)  Day 4 and 19  93 ± 48 (day 4)  (Schweigert et al 2004)
    50 ± 21 (day 19) 
Ireland (n = 13)  1 to 41 days  80 (7–193)b  (Jewell et al 2004)
United Kingdom (n = 50)  1–12 months  15 ± 1  (Canﬁ  eld et al 2003)
    
Brazil (n = 49)  30 to 120 days  3 ± 1  (Meneses and Trugo 2005)
United States (n = 12)  < 6 months  11 ± 1  (Canﬁ  eld et al 1997)
United States (n = 19)  4–32 days  146 ± 99 (day 4)  (Gossage et al 2002)
    65 ± 36 (day 16) 
    58 ± 44 (day 31) 
Australia (n = 53)  1–12 months  15 ± 1   (Canﬁ  eld et al 2003)
Canada (n = 55)  1–12 months  17 ± 1  (Canﬁ  eld et al 2003)
Chile (n = 51)  1–12 months  32 ± 3  (Canﬁ  eld et al 2003)
China (n = 52)  1–12 months  43 ± 5  (Canﬁ  eld et al 2003)
Japan (n = 51)  1–12 months  44 ± 2  (Canﬁ  eld et al 2003)
Mexico (n = 50)  1–12 months  25 ± 2  (Canﬁ  eld et al 2003)
Philippines (n = 60)  1–12 months  20 ± 2  (Canﬁ  eld et al 2003)
United States (n = 49)  1–12 months  15 ± 1  (Canﬁ  eld et al 2003)
Notes: amean ± SEM unless noted otherwise; converted from published units into μg/L for consistency; shaded rows are European data; bmedian and range; converted from 
nmol/g lipid using estimated 34 g lipid/L average from Gossage et al 2002.Clinical Opthalmology 2007:1(1) 27
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(Sommerburg et al 2000) all increasing above newborn levels 
over time in breastfed infants and dropping below newborn 
levels in formula-fed infants. Although the amounts of data 
are limited, it seems clear that if breast milk contains higher 
average levels of LZ which results in higher serum levels of 
LZ, then higher retinal levels are sure to result.
Lutein and zeaxanthin intake and 
serum concentrations in toddlers
The 2005 Dietary Guidelines for Americans recommend that 
children ages 2–3 consume one cup of vegetables per day at 
a caloric intake of 1000 kcal/day (USDA 2005). Speciﬁ  cally, 
this recommended vegetable intake should include one cup per 
week of dark green vegetables—the richest sources of LZ in 
the diet. According to the 2002 Feeding Infants and Toddlers 
Study (FITS), a national sample of US children 12–24 months 
old, mean vegetable intake in this age group was 0.4 cups per 
day (Fox et al 2006) with only 3.1% of non-Hispanic children 
consuming any dark green vegetables between the ages of 6–11 
months increasing to 7.5% between the ages of 12–24 months 
(Mennella et al 2006). This low vegetable dietary intake pattern 
would seem to present the risk of inadequate LZ consumption 
among toddlers as well.
Possible roles of lutein and 
zeaxanthin within the developing 
visual system
Although LZ are found throughout the tissues of the eye, 
they are most highly concentrated within the inner layers 
of the fovea. The area around and including the fovea is 
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Figure 1 Plasma lutein and zeaxanthin concentrations at birth and one month of age for breastfed and formula-fed infants. The bar graphs were derived from the original 
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called the macula and is of special clinical and scientiﬁ  c 
interest because it is here that we experience our best acuity 
and damage to this area leads to legal blindness. The corti-
cal areas corresponding to the fovea are greatly magniﬁ  ed 
(eg, about half of V1 is devoted to processing information 
from the macula) reﬂ  ecting the importance of this area for 
later information processing by the more anterior portions 
of the brain. The peripheral retina is essentially mature 
at birth but the fovea (ie, central 5 degrees) is so poorly 
developed as to be essentially nonfunctional (Abramov et al 
1982). Newborns can generally only discern vague shapes 
that are at a high contrast relative to their surroundings 
(Teller 1997). 
In adults, the macula has the highest concentration of 
lutein found in the eye with a predominance of zeaxanthin 
isomers over lutein at a ratio of 2.4:1 (Bone et al 1988). In 
contrast, infants (0–2 years) have an incompletely formed 
and diffuse macula with lutein predominant over zeaxanthin 
at a ratio of 1.49:1 (Bone et al 1988). At birth, the area that 
will become the macula contains both rod and cone photo-
receptors, and the photoreceptors themselves are short and 
immature (Hendrickson and Yuodelis 1984; Provis et al 
1998). The change in lutein: zeaxanthin ratio appears to be 
closely related to steps in anatomical development. 
Over the ﬁ  rst 16 weeks of life, cone cells gradually 
become predominant in the fovea with a cone cell density 
similar to that found in adults resulting in improved infant 
visual acuity (Teller 1997). During this time frame, the outer 
plexiform layer also becomes discernable within the layers of 
the retina (Provis et al 1998). The outer plexiform layer (also 
called the ﬁ  bers of Henle or receptor axon layer) is structur-
ally relevant in that it contains the highest concentration of 
LZ in the retina (Snodderly et al 1984). These changes in the 
anatomical structure of the fovea are consistent with the shift 
in lutein: zeaxanthin ratio over this time period from a still 
lutein dominant proﬁ  le (1.2–1.7:1) to a more adult proﬁ  le of 
approximately 0.7:1 (Bone et al 1988). By four years of age, 
the photoreceptors have lengthened to near-adult lengths and 
the outer plexiform layer is fully formed (Provis et al 1998). 
During this same time period, the child’s visual acuity also 
improves to near adult levels (Teller 1997).
Antioxidant functions of lutein 
and zeaxanthin
The retina is uniquely susceptible to oxidative damage com-
pared with other tissues. It is exposed to an intense energy 
source (ie, focused light from the lens) that can generate free 
radicals, high oxygen tension from the extensive vascula-
ture of the retina, photosensitizing compounds, and a high 
concentration of an easily oxidized substrate (eg, DHA-rich 
outer segments). Under these conditions, the singlet oxygen 
free radical can be readily generated (Hardy et al 2000). 
Singlet oxygen is electrophilic and preferentially reacts with 
molecules with a double bond (eg, DHA has six double 
bonds) in order to extract the hydrogen needed to return 
to ground state. When DHA loses a hydrogen atom from a 
double bond, it becomes a hydroperoxide free radical that 
can create more free radicals and begin a self-perpetuating 
chain reaction known as lipid peroxidation (Halliwell and 
Chirico 1993).
LZ are particularly well suited for protecting the retina 
from oxidative damage compared with other chain-breaking 
antioxidants in the eye like alpha-tocopherol (vitamin E). 
Lutein, for instance, can return singlet oxygen to ground 
state by temporarily becoming triplet state L and then dis-
sipating the energy as heat—a process that can be repeated 
over and over again since the lutein molecule remains intact 
after the energy transfer (Stahl and Sies 2002). Alpha-
tocopherol requires a donor antioxidant molecule to return 
to ground state after neutralizing singlet oxygen (Sies and 
Stahl 1995). Lutein is also a more effective antioxidant 
than alpha-tocopherol both in preventing lipid peroxidation 
(Fukuzawa et al 1998) and oxidation initiated by the retinal 
photosensitizer A2-PE (composed of two all-trans retinal 
molecules and a phosphatidyletanolamine molecule) (Kim 
et al 2006). This latter effect is signiﬁ  cant since A2E, the 
long-wavelength emitting ﬂ  ourophore of lipofuscin, is so 
cytotoxic to retinal pigment epithelium (RPE) cells and is 
thought to play an important role in the development of age-
related macular degeneration (Shaban and Richter 2002). 
Appropriately, LZ are found in signiﬁ  cant amounts within 
the DHA-rich photoreceptor outer segments where they 
can most effectively provide antioxidant protection (Rapp 
et al 2000). Additional evidence for antioxidant efﬁ  cacy 
comes from the fact that when LZ is exposed to more free 
radical energy than can be dissipated as heat, speciﬁ  c LZ 
oxidation products are formed. These speciﬁ  c oxidation 
products have been identiﬁ  ed in adult human eyes (Khachik 
et al 1997) providing indirect evidence that LZ are acting 
as an antioxidant in vivo.
Antioxidant protection of the eye may be particularly 
important in infants. Infants cannot down-regulate blood 
ﬂ  ow in the retinal and choroidal vasculature as well as adults; 
therefore, these vessels deliver excess oxygen to the retina Clinical Opthalmology 2007:1(1) 29
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and favor the generation and proliferation of free radical 
peroxides (Hardy et al 2000). 
The role of lutein and zeaxanthin 
as an optical ﬁ  lter
Since light must pass through LZ (ie, macular pigment) 
before reaching the receptors, it screens the vulnerable, lipid-
rich outer retinal layers (eg, the receptoral outer segments 
and RPE) according to its spectral absorption proﬁ  le. As 
shown in Figure 2, the macular pigments selectively absorb 
the portion of the visible spectrum from about 400–520 nm. 
Empirical data has shown that light can damage the retina 
depending on the wavelength of light, intensity and the length 
of exposure (Ham 1983). Light between the wavelengths of 
700 nm (red) and 400 nm (blue) can pass through the cornea 
and lens and reach the retina efﬁ  ciently to cause damage 
while ultraviolet and infrared light do not generally reach 
the retina (Reme et al 1996). Exposure to high intensity red 
light for a long period of time can produce thermal lesions 
on the retina (characterized by raising the temperature of 
the tissue at least 10 °C). In contrast, exposure to two-fold 
lower intensity blue light can produce photochemical lesions 
on the retina in the same amount of time and without raising 
the temperature of the tissue (Ham et al 1979). Such data 
have been used to calculate the “blue light hazard function” 
which is commonly used to deﬁ  ne safe exposure limits to 
short-wave (ie, blue) light (ANSI 2005). These standards are 
particularly important for occupations that require increased 
exposure to light between 400–500 nm (such as dentists using 
blue lasers to quickly cure dental compound). By absorbing 
actinic short-wave light before it damages the outer retina, 
macular pigment (MP) would reduce this damage (as shown 
by the similarity in the photoxic action spectral of the blue 
light hazard related to the MP absorbance spectra shown in 
Figure 2). Given equivalent light histories, an individual 
with high MP, would be expected to suffer less light-initiated 
damage over many years when compared with an individual 
with low MP.
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Figure 2 The absorbance spectra of macular pigment (MP) measured ex vivo (derived from tabular data in Hammond et al 2005) shown with the blue light hazard function 
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Quantifying the effects of long-term exposure to visible 
short-wave light is challenging. The epidemiology, which 
tends to be cross-sectional, is mixed (Margrain et al 2004). 
Of course, quantifying light damage over many years is very 
difﬁ  cult, especially since, as noted later, so much of the damage 
could occur very early in life. Moreover, potentially moderat-
ing factors are often not considered. For example, there is no 
data that has considered the long-term effects of individual 
differences in MP levels. For this reason, laboratory studies 
using animal models are often used with the assumption that 
the effects are direct enough that they can be extrapolated to 
the chronic human situation. Nonhuman primates are the most 
appropriate models for eye research since they are the only 
animals that have maculas and accumulate MPs like humans. 
In a study where a blue light laser (476 nm) was used to induce 
photochemical lesions in monkey eyes, adult rhesus monkeys 
fed a LZ-deﬁ  cient diet throughout life had more damage to 
their retinas than age-matched controls fed a normal chow 
diet. When deﬁ  cient monkeys were then supplemented for 
22–28 weeks with lutein or zeaxanthin (3.9 μmol/kg/d or 
about 10–15 mg per animal per day), the retina damage was 
signiﬁ  cantly reduced compared with unsupplemented, carot-
enoid-deﬁ  cient monkeys (Barker et al 2005). Supplemented 
monkeys also showed some changes in age-related eye damage 
(drusen particles) compared with unsupplemented, carotenoid-
deﬁ  cient monkeys indicating that LZ may reduce age-related 
damage to the eyes (Leung et al 2006). In the quail model, 
zeaxanthin supplementation (36 μg/kg diet) of carotenoid-
deﬁ  cient quail prevented photoreceptor apoptosis induced 
by intermittent bright white light exposure (Thomson et al 
2002). In rats, feeding 1 gram per day of Lycium barbarum 
L. fruit (wolfberry) to normal Sprague Dawley rats reduced 
the amount of retina damage induced by bright light exposure 
when compared with rats fed a normal diet (Na et al 1995). L. 
barbarum is an extremely rich source of zeaxanthin containing 
82 mg zeaxanthin per 100 g weight (Weller and Breithaupt 
2003). These experimental models show that dietary LZ can 
protect the retina from light damage, especially damage due 
to short-wave light.
If MP does protect the receptors and RPE from actinic 
damage, it is probably meaningful that individuals vary so 
widely in the amount of MP they possess. As measured in 
vivo in adult subjects, individual differences in MP density 
tend to be large, ranging from a maximum in some individuals 
of 1.5 optical density units at 460 nm (3% transmission) 
to a minimum of near zero density (100% transmission) 
(Hammond et al 1997) (with an average density of about 
0.36, SD = 0.22; Mares et al 2006). MP density in infants and 
children also varies between individuals (Bone et al 1988; 
Bour et al 2002). As noted, formula-fed infants with lower 
intake of LZ would be expected to have lower retinal levels 
compared with infants fed with LZ-rich breast milk.
Lower MP levels in children may be particularly mean-
ingful since short wavelength (SW) light may pose a par-
ticular hazard to infants and young children. Infants are born 
with clear lenses that gradually yellow throughout life (due 
to color changes in proteins and other lens constituents). This 
yellowing progressively blocks the SW light passing through 
the lens as a linear function of age (Dillon et al 2004). For 
example, Werner (1982) obtained lens density data in sub-
jects from birth until 70 years of age using visually evoked 
cortical potentials as the criterion response. He found that 
lens density at 400 nm increased (~0.02 O.D. per year) by a 
factor of 22 when comparing the average one-month old with 
an average 70-year old. Expressed in relative terms, about 
70%–80% of the SW light passes through the lens in 0–2 year 
olds, 60%–70% in 2–10 year olds but only 20% of SW light 
is transmitted in 60–90 year olds. Data from various sources 
is summarized in Reme and colleagues (1996). 
Finally, ﬁ  ltering SW light may also have a number of 
meaningful optical effects as summarized by Nussbaum and 
colleagues (1981). These include: (1) reducing the effects of 
chromatic aberration; (2) decreasing glare discomfort and 
disability; (3) increasing visibility outdoors by absorbing 
“blue haze”; and (4) enhancing contrast (ie, by differential 
absorption of a background with shorter wavelengths than 
a target). Yellow ﬁ  lters like MP have also been shown to 
improve magnocellular function which could enhance read-
ing performance, motion sensitivity, accommodation, and 
convergence particularly in reading-impaired children (Ray 
et al 2005).
Other possible inﬂ  uences of lutein 
and zeaxathin on neural function 
within the visual system
All of the major hypotheses of MP function are based on 
just two fundamental characteristics of the pigments: their 
ﬁ  ltering and antioxidant properties. In addition to their ﬁ  lter-
ing and antioxidant properties, however, LZ have a number 
of other known characteristics that might have meaningful 
inﬂ  uences on the visual system. For example, although most 
highly accumulated in and around the foveal depression, LZ, 
unlike the many other carotenoids circulating in the blood, 
are found throughout the tissues of the eye (Yeum et al 1995; Clinical Opthalmology 2007:1(1) 31
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Bernstein et al 2001) and at most layers of the visual system. 
Craft and colleagues (2004), for instance, found that LZ are 
the dominant carotenoids within the brain and comprise some 
66%–77% of the total carotenoid concentration. There, these 
pigments would be optimally placed to inﬂ  uence central 
visual processing (eg, they are concentrated in the gray matter 
of the occipital region). LZ are also known to associate with 
the microtubules of axons. During embyogenesis, axons grow 
over extended distances to reach their targets. Once these 
targets have been achieved, the microtubules, cylindrical 
protein lattices, form the cytoskeleton of visual neurons. 
The walls of microtubules are formed by subunit proteins 
including tubulin. Whereas traditionally microtubules have 
been regarded as purely structural in nature, more recent 
evidence (Glanz 1997; Maniotis 1997a, 1997b) has shown 
that they may serve mechanical signaling and communicative 
functions (eg, by inﬂ  uencing second-messenger systems). 
Bernstein and colleagues (1997) originally identiﬁ  ed tubulin 
as a possible binding protein for the macular carotenoids. 
Using molecular modeling, Crabtree and colleagues (2001) 
conﬁ  rmed tubulin as the most likely binding protein for reti-
nal LZ and suggested that a major function of the macular 
carotenoids, previously unconsidered, is to modulate the 
dynamic instability of microtubules. In any event, LZ are 
found in many locations outside of the inner layers of the 
fovea, albeit at relatively low concentrations. They are also 
found in many locations within the cell including the cell 
membrane and cytoskeleton. It is possible that the presence of 
the pigments is simply incidental and has no actual function. 
It is also possible, however, that the pigments inﬂ  uence the 
function of the neurons that they so closely and structurally 
associate with. 
The idea that the MP carotenoids might have an actual 
metabolic role is not new. Dartnall and Thomson (1949) orig-
inally suggested that LZ facilitate oxygen respiration within 
the fovea. The xanthophylls do often serve this function in 
hypoxic situations in other animals and plants (Karnaukhov 
1990). The inner layers of the foveal depression, where MP 
is most densely concentrated, are typically avascular and 
hypoxic. LZ would, according to this idea, be positively 
related to oxygen metabolism, particularly in the fovea. For 
example, MP might be expected to be related to aspects of 
foveal architecture that might be expected to inﬂ  uence oxy-
gen utilization (eg, the size of the avascular zone). Consistent 
with such a possibility, Aleman and colleagues (2001) and 
Liew and colleagues (2006) found that retinal thickness 
(which would, presumably, cause greater hypoxia in the 
inner foveal layers due to less oxygen diffusion from the 
more distant posterior choroid) was positively related to MP 
density. Dwyer and colleagues (2001) originally suggested 
that lutein could influence blood flow (most probably 
including retinal blood ﬂ  ow) by preventing atherosclerotic 
changes through inhibition of low density lipoprotein-
induced migration of plaque-forming monocytes to artery 
walls. As noted, Hardy and colleagues (2000) argued that it 
was the absence of autoregulation of choroidal blood ﬂ  ow 
in the infant that leads to increased oxidative stress in the 
newborn retina. 
Another possibly relevant feature of carotenoids is their 
ability to enhance gap junctional communication (Stahl and 
Sies 2001). Gap junctions increase intracellular communica-
tion between glial and neuronal cells. Acting as portals, they 
inﬂ  uence propagation of action potentials, second-messenger 
systems and the movement of metabolites and electrolytes. 
Within the retina, gap junctions are crucial to light processing via 
lateral connections (Cook and Becker 1995; Vaney et al 1998). 
Gap junctions may therefore be vital to the developing neural 
circuitry within the visual system (Roerig and Feller 2000). 
Evidence from such diverse sources suggests that, in 
addition to the classic hypotheses of MP function, LZ might 
play a facilitative role in neural processing. Gutherie and 
colleagues (2005) originally evaluated this possibility by 
measuring scotopic noise. It is generally thought that visual 
thresholds that depend primarily on receptoral processes are 
determined early in life. For example, most absolute thresh-
olds are thought to reach adult levels between about 2–4 
months (Brown 1990). Although intrinsic noise can arise at 
numerous levels of the visual system, noise associated with 
scotopic thresholds is thought to originate at the input stage 
(ie, at the level of the retina) (van Rossum and Smith 1998). 
When in a fully dark-adapted state (ie, scotopic), the visual 
system is maximally sensitive, making the effects of noise 
easily measurable. LZ are found within rod outer-segments 
and therefore a relation to rod function is feasible. As shown 
in Figure 3, intrinsic noise was signiﬁ  cantly related to MP 
optical density (MPOD). Such a relation is biologically 
plausible. As noted, LZ are found throughout the retina 
including within rod outer segments (Rapp et al 2000). It 
is likely that higher levels of LZ in the macula (ie, the MP 
values that were measured) correlate with LZ in the outer 
segments. Such a relation suggests that higher LZ levels in 
rod outer segments might help improve the efﬁ  ciency of rod 
functioning leading to less variability in threshold response 
(their measure of noise).Clinical Opthalmology 2007:1(1) 32
Zimmer and Hammond
Gutherie and Hammond’s data (2005) suggest that MP 
might be related to dynamic receptoral function. There is 
evidence also that MP might be related to post-receptoral 
processing. Hammond and Wooten (2005) found a mod-
erately strong relation between MP and critical flicker 
fusion thresholds (CFF) that was independent of age. CFF is 
largely regarded as a measure of temporal processing speed. 
Evidence suggests that the CFF (the average of descending 
ﬂ  icker and ascending fusion thresholds) is probably deter-
mined post-receptorally (Powell 1983; Curran 1990). This 
possibility is based on the observation that the retina (as mea-
sured by electroretinography) responds to ﬂ  icker even after 
a subject has reported fusion (Brown 1965) and correlates 
with measures of cortical arousal like electroencephalogram 
(Gortelmeyer and Wieman 1982; Grunberger et al 1982). 
Thus, diseases and drugs that inﬂ  uence central nervous 
system function often inﬂ  uence CFF thresholds in the same 
direction (Grunberger et al 1982; MacNab et al 1985; Curran 
1990). For example, barbituates decrease CFF thresholds and 
amphetamines increase CFF thresholds. In most situations, 
a lower threshold implies increased sensitivity (eg, a lower 
energy threshold for detection means a higher sensitivity). 
In the case of flicker, however, a higher threshold for 
fusion implies a higher ﬂ  icker sensitivity. Like the MP–noise 
relation, the MP–CFF relation reported by Hammond and 
colleagues (2005) was not age-dependent (ie, it is also evi-
dent for the younger subjects). CFF thresholds (reviewed by 
Teller 1997) reach adult levels in early infancy as opposed 
to some other spatial vision functions, like vernier acuity, 
that develop much later (~5–6 years of age) and appear not 
to be associated with MP (Engles et al in press). 
Conclusion
The question of how LZ inﬂ  uence the developing visual 
system is open. There is, however, convincing evidence 
that a lack of LZ from birth can produce distinct anatomi-
cal changes within the retina and RPE. For example, Leung 
and colleagues (2004) studied the effects of raising Rhesus 
monkeys on diets containing no LZ. Compared with mon-
keys raised on normal diets, these xanthophyll-free monkeys 
displayed changes in the anatomy of their RPE (eg, in the 
density and distribution of RPE cells) that could be largely 
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Figure 3 The relation between macular pigment optical density (measured at 460 nm, 1-degree test) and intrinsic noise within the scotopic system (Y = 0.87 + –0.43X). r = 
–0.38; p < 0.01; and n = 39 (mean age = 40; SD = 8 years). Macular pigment was measured at 460 nm using a one-degree test stimulus and a psychophysical technique based 
on heterochromatic ﬂ  icker photometry. For details regarding the procedure and apparatus see Wooten et al 1999. Scotopic thresholds were assessed in Maxwellian view 
using a 1.85-deg, 510-nm circular test stimulus located at 10° eccentricity in the left visual ﬁ  eld using a two-alternative forced-choice paradigm (an average of 200 trials per 
participant was obtained). Individual trials were transformed into binomial data (the inverse of the normal probability integral) and then ﬁ  t with a weighted linear regression. 
We then deﬁ  ned “intrinsic noise” as the average deviation from this line (see Gutherie et al 2005).Clinical Opthalmology 2007:1(1) 33
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reversed by supplementing LZ (especially in conjunction 
with n-3 fatty acids, a precursor of DHA) later in life. Their 
results suggested that LZ might be important to the matura-
tion of the fovea based on metabolic effects not associated 
with protection. With respect to the latter, it is becoming 
increasingly clear that protection very early in life is critical 
to preventing degenerative disease later in life. Carotenoid-
deﬁ  cient monkeys also develop signs of premature aging and 
damage (drusen and transmission defects) in their maculas 
years earlier than these signs develop in normal chow-fed 
monkey (Neuringer et al 2003). 
One might argue that humans evolved in an environment 
where dietary intake of carotenoid-rich fruits and vegetables 
was high (ie, most food is gathered in hunter and gathering 
societies). Humans also were exclusively breast-fed until 
relatively recently in our evolutionary history. Although the 
effects of deviation from this “natural state” are not known, 
they could be meaningful. Of course, empirical study of 
this question in humans is difﬁ  cult. Randomized, placebo-
controlled trials of infant formula with and without lutein 
could require many years of follow-up before changes in the 
retina and RPE are detectable. Until such data are available, 
there is reason to believe lutein may have long term beneﬁ  ts 
based both on animal data and by examining the mechanisms 
by which damage accumulates in the retina throughout life. 
For example, one mechanism through which early intake of 
LZ could have long-term health beneﬁ  ts is through reduc-
tion of cumulative eye damage. Over the course of life, a 
cellular waste product called lipofuscin accumulates in the 
RPE of the eye. Lipofuscin is a mass of oxidized proteins, 
lipids, and other compounds created through the incomplete 
digestion of photoreceptor outer segments in the lysosomes 
of RPE (Sparrow and Boulton 2005). Lipofuscin cannot be 
transported out of the cell, and the accumulation of lipofuscin 
in RPE is accelerated by increased oxygen (Wihlmark et al 
1996), light exposure (Ben-Shabat et al 2002) or the absence 
of macular pigment (Leung et al 2006). In vitro, LZ inhibit 
the formation of lipofuscin in cultured RPE (Sundelin and 
Nilsson 2001). The results of failing to forestall lipofuscin 
accumulation can be seen in vivo in that primates subjected 
to a life-long carotenoid deﬁ  ciency develop lipofuscin-related 
damage (drusen) much earlier than primates fed normal diets 
(Neuringer et al 2003).
Among the various components that make up lipofuscin is 
a retinal-derived compound called A2-PE (Lamb and Simon 
2004). A2-PE is a photosensitizing ﬂ  uorophore (a molecule 
that absorbs light energy and releases it as ﬂ  uorescence at 
a different wavelength) that creates oxygen free radicals 
when exposed to blue light. LZ are efﬁ  cient quenchers of the 
photochemical oxidation caused by A2-PE—more so than 
alpha-tocopherol, another biological antioxidant (Kim et al 
2006). Through this mechanism, LZ may help reduce the retina 
damage caused by lipofuscin in the RPE. As much as half of 
the lifetime accumulation of lipofuscin in RPE may occur in 
the ﬁ  rst ﬁ  ve years of life (Wing et al 1978; Feeney-Burns et al 
1984). Increasing MP earlier in life could theoretically slow the 
accumulation of lipofuscin as well as reduce the free radical 
oxidants that it produces. Given the low risk and clear potential 
beneﬁ  t, it would be prudent to increase lutein consumption 
earlier in life while further evidence of its beneﬁ  ts emerge.
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